Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 8, 2012, Pages 1336-1343

  Weng, Shaofan ^a,b   Wang, Hua ^a   Chen, Weihong ^b   Katz, Matthew H ^a   Chatterjee, Deyali ^a   Lee, Jeffrey E ^a   Pisters, Peter W ^a   Gomez, Henry F ^a   Abbruzzese, James L ^a   Fleming, Jason B ^a   Wang, Huamin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHOSPHATASE; PROTEIN PHOSPHATASE 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PHOSPHOPROTEIN PHOSPHATASES; PROGNOSIS; RNA, MESSENGER; TISSUE ARRAY ANALYSIS;

EID: 84864819587     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0223     Document Type: Article

References (27)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Hernandez JM, Morton CA, Al-Saadi S, Villadolid D, Cooper J, Bowers C, et al. The natural history of resected pancreatic cancer without adjuvant chemotherapy. Am Surg 2010;76:480-5.
3. Wera S, Hemmings BA. Serine/threonine protein phosphatases. Biochem J 1995;311:17-29.
4. Cohen PT. Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci 1997;22:245-51. (Pubitemid 27310944)
5. Brewis ND, Street AJ, Prescott AR, Cohen PT. PPX, a novel protein serine/threonine phosphatase localized to centrosomes. EMBO J 1993;12:987-96. (Pubitemid 23095847)
6. Millward TA, Zolnierowicz S, Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999;24:186-91. (Pubitemid 29348452)
7. Dounay AB, Forsyth CJ. Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor. Curr Med Chem 2002;9:1939-80. (Pubitemid 35256499)
8. Hastie CJ, Cohen PT. Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters. FEBS Lett 1998;431:357-61. (Pubitemid 28352987)
9. Wang B, Zhao A, Sun L, Zhong X, Zhong J, Wang H, et al. Protein phosphatase PP4 is overexpressed in human breast and lung tumors. Cell Res 2008;18:974-7.
10. Wang H, Wang H, Zhang W, Fuller GN. Tissue microarrays: applications in neuropathology research, diagnosis, and education. Brain Pathol 2002;12:95-107. (Pubitemid 33131366)
11. Wang H, Song X, Logsdon C, Zhou G, Evans DB, Abbruzzese JL, et al. Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. Cancer Res 2009;69: 1063-70.
12. Helps NR, Brewis ND, Lineruth K, Davis T, Kaiser K, Cohen PT. Protein phosphatase 4 is an essential enzyme required for organisation of microtubules at centrosomes in Drosophila embryos. J Cell Sci 1998;111:1331-40. (Pubitemid 28274385)
13. Sumiyoshi E, Sugimoto A, Yamamoto M. Protein phosphatase 4 is required for centrosome maturation in mitosis and sperm meiosis in C. elegans. J Cell Sci 2002;115:1403-10. (Pubitemid 34428698)
14. Nakada S, Chen GI, Gingras AC, Durocher D. PP4 is a gamma H2AX phosphatase required for recovery from the DNA damage checkpoint. EMBO Rep 2008;9:1019- 26.
15. Lee DH, Pan Y, Kanner S, Sung P, Borowiec JA, Chowdhury D. A PP4 phosphatase complex dephosphorylates RPA2 to facilitateDNA repair via homologous recombination. Nat Struct Mol Biol 2010;17:365-72.
16. Hu MC, Tang-Oxley Q, Qiu WR, Wang YP, Mihindukulasuriya KA, Afshar R, et al. Protein phosphatase X interacts with c-Rel and stimulates c-Rel/nuclear factor kappaB activity. J Biol Chem 1998; 273:33561-5. (Pubitemid 29005741)
17. Yeh PY, Yeh KH, Chuang SE, Song YC, Cheng AL. Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation. J Biol Chem 2004;279:26143-8. (Pubitemid 38798759)
18. Zhou G, Mihindukulasuriya KA, MacCorkle-Chosnek RA, Van Hooser A,Hu MC, Brinkley BR, et al. Protein phosphatase 4 is involved in tumor necrosis factor-alpha-induced activation of c-Jun N-terminal kinase. J Biol Chem 2002;277:6391-8. (Pubitemid 34968433)
19. Zhou G, Boomer JS, Tan TH. Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1. J Biol Chem 2004;279: 49551-61. (Pubitemid 39625843)
20. Mihindukulasuriya KA, Zhou G, Qin J, Tan TH. Protein phosphatase 4 interacts with and down-regulates insulin receptor substrate 4 following tumor necrosis factor-alpha stimulation. J Biol Chem 2004;279: 46588- 94.
21. Zhang X, Ozawa Y, Lee H, Wen YD, Tan TH, Wadzinski BE, et al. Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev 2005;19: 827-39.
22. Inostroza J, Saenz L, Calaf G, Cabello G, Parra E. Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity. Biol Res 2005;38:163-78. (Pubitemid 41535617)
23. Mourtada-Maarabouni M, Williams GT. Protein phosphatase 4 regulates apoptosis in leukemic and primary human T-cells. Leuk Res 2009;33:1539-51.
24. Lucas CM, Harris RJ, Giannoudis A, Copland M, Slupsky JR, Clark RE. Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression. Blood 2011;117:6660-8.
25. Li W, Chen Z, Gong FR, Zong Y, Chen K, Li DM, et al. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway. Eur J Cancer 2011;47:2654- 64.
26. Li W, Xie L, Chen Z, Zhu Y, Sun Y, Miao Y, et al. Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis. Cancer Sci 2010;101:1226-33.
27. Li W, Chen Z, Zong Y, Gong F, Zhu Y, Zhu Y, et al. PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKalpha and sustained activation of the NF-kappaB pathway. Cancer Lett 2011;304:117-27.